Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Clinical Trial

IMPORTANCE: Stereotactic ablative radiotherapy (SABR) is a standard treatment option in patients with medically inoperable early-stage non–small cell lung cancer (NSCLC), yet the pathologic complete response (pCR) rate after SABR is unknown. Neoadjuvant SABR in patients with cancer who are fit for r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Palma, David A., Nguyen, Timothy K., Louie, Alexander V., Malthaner, Richard, Fortin, Dalilah, Rodrigues, George B., Yaremko, Brian, Laba, Joanna, Kwan, Keith, Gaede, Stewart, Lee, Ting, Ward, Aaron, Warner, Andrew, Inculet, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512269/
https://ncbi.nlm.nih.gov/pubmed/30789648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.6993
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados